IC
KRTX

Ikarian Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Ikarian Capital’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100,000
Closed -$12.7M – 170
2022
Q2 		$12.7M Buy
100,000
+50,000
+100% +$5.75M 2.31% 13
2022
Q1 		$6.34M Buy
+50,000
New +$5.63M 0.83% 35

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Ikarian Capital's KRTX Position: Q3 2022 in Review

Ikarian Capital sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2022, closing a stake of 100,000 shares — an estimated $12.7M sold.

Ikarian Capital first reported a position in KRTX in Q1 2022 and held it in 2 quarters. The position peaked at $12.7M in Q2 2022. 257 funds tracked by Wall St. Rank hold KRTX as of Q3 2022.

  • Ikarian Capital reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 100,000 Karuna Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $12.7M.
  • Ikarian Capital first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Ikarian Capital's Karuna Therapeutics, Inc. Common Stock position peaked at $12.7M in Q2 2022.
  • 257 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.